| |
Categories of manuscripts
Brief Articles. Manuscripts in this category are in the same format as a Regular Article,
but are generally less than 20 total manuscript pages in length (double-spaced) and have three or less figures or tables.
Regular
Manuscripts. Manuscripts submitted in this category are expected to be concise, well organized, and clearly written. Acceptance is
based on originality and importance to the field of blood and marrow transplantation. These manuscripts are reviewed by two or more experts
in the field, and detailed comments from the reviewers are generally returned to the authors. Manuscripts requiring extensive revision
will be at a disadvantage for publication. Manuscripts are submitted with the understanding that they are original contributions and
do not contain data that have been published elsewhere, including symposia volumes, etc. Meeting abstracts do not constitute prior publication.
Rapid Communications. Definitive papers of exceptional scientific importance within the discipline of blood and marrow transplantation
will be considered for expedited review and publication. Consideration as a Rapid Communication must be requested at the time of submission
by the authors and requires approval by the Editorial Board. Papers that the Editors decide not to process as Rapid Communications will
be handled as regular manuscripts unless the authors choose to have them returned without further review. Criteria for selection as Rapid
Communications include originality, importance, and the potential value of accelerated publication to the readers of Biology of Blood
and Marrow Transplantation. Decisions on these manuscripts will be made within four weeks of receipt and in general will not be
accompanied by detailed reviewers' comments. Although there is no page limit for manuscripts in this category, clear and concise presentation
of data is required. Manuscripts requiring extensive revisions or editing will be at a disadvantage for publication in this category.
Case reports, methods papers, or preliminary studies should not be submitted for consideration as Rapid Communications.
Review
Articles. Review articles on topics of broad interest are highly desired and may be solicited by the Editor-in-Chief. Individuals
who wish to write a review article should correspond with the Editor in Chief regarding the appropriateness of the proposed topic. Such
articles are expected to be thorough and detailed and should include appropriate references to the literature. The addition of tables
and figures to summarize critical points is encouraged. These articles are reviewed by the Editors and other expert reviewers before
a final decision regarding publication is made, and revisions may be required. Manuscript submission fees and page charges are not assessed
on review articles.
Clinical Reviews. Short, highly focused articles that review topics related to therapy, diagnosis, or
other clinical issues in hematology may be published as Clinical Reviews. Authors who wish to write a Clinical Review should correspond
with the Editor in Chief regarding the proposed topic. Such manuscripts will be reviewed by expert reviewers and will be accepted for
publication based on their educational value and clarity. Manuscript submission fees and page charges are not assessed on review articles.
Editorials. Concise, invited commentaries on articles published in Biology of Blood and Marrow Transplantation or
other topics in hematology are highly desired.
Letters. Letters to the Editor commenting on articles published in Biology
of Blood and Marrow Transplantation are welcomed. Letters should be as concise as possible (no more than three double-spaced pages),
include no more than 10 references, and should have titles.
Manuscript Submission and Handling
Biology of Blood
and Marrow Transplantation utilizes a
web-based manuscript submission and peer-review system.
Authors should submit their manuscripts,
with figures and
tables, electronically at the journal Web site, www.bbmt.org.
Authors can also visit  http://ees.elsevier.com/ybbmt. Complete
instructions are available at the Web site. If authors
experience
any difficulty during the submission process or
require any assistance, they should contact authorsupport@
elsevier.com.
If authors do not receive an e-mail confirmation
of submission within 24 hours, it may be an indication
that the manuscript has not been
received by the editorial
office. In this instance, authors should contact the editorial
office (Robert Korngold, PhD, The Cancer Center,
Hackensack University Medical Center, David Joseph Jurist Institute for Research/ Rm 356 30, Prospect Avenue, Hackensack, NJ 07601;
Tel:
(201) 336-8664; Fax: (201) 336-8696; E-mail: rkorngold@humed.com).
Copyright. All material in Biology of
Blood and Marrow Transplantation represents the opinions of the authors and does not reflect the opinions of the American Society
for Blood and Marrow Transplantation (ASBMT), Elsevier Inc., or the institutions with which the authors are affiliated. Authors submitting
manuscripts do so with the understanding that, if accepted, copyright in the article, including the right to reproduce the article in
all forms and media including electronic media, shall be assigned exclusively to the ASBMT and authors will be requested to sign a copyright
release form.
NIH Public Access Policy Compliance
To comply with the NIH Public Access Policy, Elsevier will deposit
to PubMed Central (PMC) author manuscripts on behalf of authors reporting NIH funded research. The NIH policy requires that NIH-funded
authors submit to PubMed Central (PMC), or have submitted on their behalf, their peer-reviewed author manuscripts, to appear on PMC no
later than 12 months after final publication. Elsevier will send to PMC the final peer-reviewed manuscript, which was accepted for publication
and sent to Elsevier's production department, and that reflects any author-agreed changes made in response to peer-review comments. Elsevier
will authorize the author manuscript's public access posting 12 months after final publication. Following the deposit by Elsevier, authors
will receive further communications from the NIH with respect to the submission.
Organization of the Manuscript
Organize submitted manuscripts as follows: Cover Letter, Title Page (including title; authors' full names, academic degrees, and affiliations;
corresponding author's address, phone number, fax number, and e-mail address; and a short title), Financial Disclosure Statement, Abstract,
Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Tables, Figure Legends, and Figures. Manuscripts
should be double-spaced and formatted for standard paper with 1-inch margins.
Cover Letter. Please identify the name, address,
phone number, fax number, and e-mail address of the corresponding author. The cover letter should also specify the category of manuscript
(such as Rapid Communication). Papers that the Editors decide not to process as Rapid Communications will be handled as regular manuscripts
unless the authors request in the cover letter that the manuscript be returned without further review. The cover letter also should indicate
where appropriate that the authors are willing to pay the extra costs involved in publishing any color photographs. At the end of the
cover letter, all authors must sign a statement that they have reviewed the manuscript, agree with its contents, and consent to its submission
to BBMT. The author agreement can alternatively be e-mailed as a pdf separately to the Editorial Office: Robert Korngold, Ph.D;
E-mail: rkorngold@humed.com.
Financial Disclosure Statement. Authors must disclose any primary financial relationship
with a company that has a direct financial interest in the subject matter or products discussed in the submitted manuscript, or with
a company that produces a competing product. These relationships (such as honoraria, ownership of stock, patents, or consulting fees)
and any direct support of research by a commercial company will be included in the Acknowledgements section of the published article.
References. Include double-spaced references in numerical order at the end of the article according to the order of citation
in the text. The names of all authors should be given unless there are more than 6, in which case the names of the first 3 authors should
be given, followed by "et al." Abbreviate the names of journals according to the abbreviations used in the latest edition of Index
Medicus, Superintendent of Documents, US Government Printing Office, Washington, DC 20402. References to abstracts and letters must
be appropriately identified. References to personal communications, unpublished observations, and manuscripts submitted and "in preparation"
must appear parenthetically in the text.
Please use the following form for references:
9. Singer JW, Charbord P, Keating
A, et al. Simian virus 40?transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal
and hematopoietic characteristics. Biol Blood Marrow Transplant. 1995;7:464-469.
10. Cone RD, Williams DA, Davies
TF. Establishment of differentiated cell lines using oncogene-containing retroviral vectors. In: Glunzman Y, Hughes SH, eds. Viral
Vectors. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1993:34-39.
Footnotes and Abbreviations. Footnotes
should appear at the bottom of the page. Abbreviations
should be defined at their first use and applied consistently throughout the article. Do not use nonstandard abbreviations or abbreviate
terms appearing fewer than three times. Give the chemical name of a compound after the first use of the trivial name. The trivial name
may follow throughout the article.
Tables. Each table should be printed or typed on a separate page, appropriately numbered
and cited in numerical order in the text. Legends giving sufficient explanation to make the data intelligible without reference to the
text must be typed on the same page.
Figures and Figure Legends. Figures must be cited in the
text in numerical order using
arabic numerals. Figures
should be generated in .tif format; see instructions on Web
site. Figure legends should be double-spaced on
a separate
page and should include a brief title and a concise explanation
of each figure. Part of the cost of publishing color
photographs
will be borne by the authors and payment must
be made to the publisher prior to publication.
Supplementary Material for Online
Publication. In cases where essential information associated with an article is too extensive for print publication (e.g., data
sets, additional figures, video files), this content can be included as online-only supplemental information. Supplementary material
file(s) should be provided at the time of manuscript submission, and should be called out in the text (egg, Table S2, Fig S1, Item S4).
Titles and/or legends for each supplementary figure or item should be included as the final page of the manuscript document. Unless otherwise
requested, supplementary material will generally be corrected for style, grammar, and format.
Proofs. Authors of accepted
manuscripts will receive galley
proofs as pdf files via e-mail directly from the publisher and
are responsible for proofreading. Except
for correcting typesetting
errors, authors may be charged for extensive alterations.
Corrections should be returned within 48 hours to
avoid delay in publication.
Reprints.
Reprints must be ordered and paid for in advance. An order form with the cost
of reprints and instructions for payment will be sent directly from the publisher with page proofs. Reprint orders, payments, and inquiries
should be directed to Elsevier.
Announcements.
Announcements of meetings that are of interest to the readers of Biology
of Blood and Marrow Transplantation should be sent to the Editor at least three months before the first day of the month of issue.
Fees for announcements vary depending on their size and number of insertions; please call the Editorial Office for details.
Advertisements.
Direct inquiries about advertising and classified ads to Jim Cunningham Associates, 180 Old Tappan Rd, Old Tappan, NJ 07675, telephone
(201) 767-4170; fax (201) 767-8065.
Updated July 2010
|
| |
|
